No matter whether you are a seasoned programmer or you simply want to take your first steps in writing code, Repl.it wants to help you get from idea to result as fast as possible — without complicated ...
Zacks Investment Research on MSN
REPL Stock Plunges 54% in 3 Months After FDA Rejects Skin Cancer Drug
Replimune Group’s REPL share price tumbled 54.2% over the past three months. The massive setback was observed after the FDA issued a complete response letter (CRL) in July, against the biologics ...
Multiple analysts have issued price targets for $REPL recently. We have seen 4 analysts offer price targets for $REPL in the last 6 months, with a median target of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback